Cuvitru

(immunoglobulin G, human)
Check Coverage Restrictions
Or select your Insurance from the list below:

Dosage & Administration

For subcutaneous infusion only.

Administer at regular intervals from daily up to every two weeks (biweekly).

Individualize dose based on the patient's pharmacokinetic and clinical response.

Monitor serum IgG trough levels regularly to guide subsequent dose adjustments and dosing intervals as needed.

Switching from Immune Globulin Intravenous (Human) treatment (IGIV) or adult patients switching from HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]:

Initial Weekly dose =Previous IGIVor HYQVIA dose (in grams) × 1.30
No. of weeks between IGIV or HYQVIA doses

Cuvitru Prescribing Information

Cuvitru Prior Authorization Resources

Benefits investigation

Cuvitru Financial Assistance Options

Copay savings program

View more

Cuvitru PubMed™ News

    Cuvitru Patient Education

    Getting started on Cuvitru

    Patient toolkit